Genomic and Proteomic Analysis of Sars Cov for Exploring Its Herbal Remedies Through Molecular Docking
International Journal of Drug Delivery Technology · 19.05.2026 · 16 (30s)
DOI: 10.25258/ijddt.16.30s.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.05.2026. Verfasst von Dharmendra Singh Chaudhary und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The novel coronavirus (2019-nCoV) has been recently identified in patients who are suffering from acute respiratory disease. The novel coronavirus SARS-CoV-2, first identified in Wuhan, China in 2019, is genetically related to SARS-CoV, which caused the 2002-2003 severe acute respiratory syndrome outbreak. The decadelong studies on finding the structural receptors of SARS-CoV have shown key players like - SARS-CoV spike protein (2GHV), host receptor angiotensin-converting enzyme 2 (ACE2) (1R4L), the RNA binding domain of N-protein from SARS (2OG3), and COVID-19 main protease (6LU7) which are responsible for the regulation of the cross-species as well as human-to-human transmissions of SARS-CoV. A large pool of diverse herbal compounds can be found in the traditional medicines of several Asian countries, which are still very much entrusted over the modern allopathic medicines. These first-line treatments show great therapeutic activities including antiviral activities with low cost and negligible side-effects. This study aims to estimate and assess the antiviral potential of these easily available herbal compounds against human coronavirus infections using molecular docking techniques. In the current study, 5 potential antiviral compounds were selected through intense literature studies. The molecular docking of all the 5 selected herbal compounds was done against 4 target proteins (2GHV, 1R4L, 2OG3 & 6LU7) using AutoDock Vina, to study the comparative interaction between the selected ligands and target proteins. Molecular docking using AutoDock Vina revealed that Amentoflavone exhibited the strongest binding affinity with ACE2 (-15.1 kcal/mol), suggesting potential inhibitory activity. Though the results show that compound Amentoflavone proved to be most promising against the human coronavirus, the other compounds were also showing favourable results against the COVID-19. These studies can help in exploring more such herbal compounds against viruses of the corona family, so that further in vitro studies can be carried out in near future.
Zitieren
APA
Chaudhary, D. S., Paswan, A., Mishra, P., Tripathi, T., Dubey, S., Nigam, M., & Awasthi, G. (2026). Genomic and Proteomic Analysis of Sars Cov for Exploring Its Herbal Remedies Through Molecular Docking. International Journal of Drug Delivery Technology, 16(30s). https://doi.org/10.25258/ijddt.16.30s.11
Vancouver
Chaudhary DS, Paswan A, Mishra P, Tripathi T, Dubey S, Nigam M, et al. Genomic and Proteomic Analysis of Sars Cov for Exploring Its Herbal Remedies Through Molecular Docking. International Journal of Drug Delivery Technology. 2026;16(30s). doi:10.25258/ijddt.16.30s.11
BibTeX
@article{Chaudhary2026,
author = {Chaudhary, Dharmendra Singh and Paswan, Arti and Mishra, Priyanka and Tripathi, Tripti and Dubey, Saijasi and Nigam, Mohit and Awasthi, Garima},
title = {Genomic and Proteomic Analysis of Sars Cov for Exploring Its Herbal Remedies Through Molecular Docking},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {30s},
doi = {10.25258/ijddt.16.30s.11}
}
EUVIMED